Why RX Rebates Hijack Your Budget

In this episode of Blueprints for Better Benefits, we unpack one of the most misunderstood drivers of rising healthcare costs: pharmacy rebates. Rebates are often positioned as savings, but in practice they frequently inflate drug prices, reduce transparency, and shift costs onto employers and employees. We explain how Pharmacy Benefit Managers (PBMs) negotiate rebates, why those dollars rarely reduce premiums or out-of-pocket costs, and how incentives favor higher-priced drugs over lower-cost alternatives. You’ll learn how vertical integration across insurers, PBMs, specialty pharmacies, and providers allows carriers to capture revenue at multiple levels—while remaining compliant with ACA Medical Loss Ratio rules. The result is a system where employers pay more each year with little visibility into where their healthcare dollars actually go. We also break down real-world examples, including why prices for drugs like Humira increased even after biosimilars entered the market, and why significantly cheaper options often remain off formularies. If you’re responsible for benefits, budgeting, or financial strategy, this episode offers clarity, and a better way forward. In This Episode, We Cover Why pharmacy rebates don’t work like consumer discounts How PBM incentives reward higher-priced drugs Why rebate dollars don’t lower premiums Vertical integration and its impact on employer costs The true flow of pharmacy dollars, from employer to manufacturer Why transparency is essential to cost control Who This Episode Is For ✔ Employers with 50–750 employees ✔ CFOs and finance leaders ✔ HR and benefits decision-makers ✔ Organizations exploring self-funding or alternative models Connect with Triforta Ready to take control of your pharmacy spend? 📩 [email protected] 🌐 https://www.triforta.com/education 🔗 LinkedIn @Triforta-partners We are Triforta, and we exist to help employers build transparent, predictable, and sustainable healthcare strategies.